In the BioHarmony Drug Report Database

"Preview" Icon

Tolcapone

Tasmar (tolcapone) is a small molecule pharmaceutical. Tolcapone was first approved as Tasmar on 1997-08-27. It is used to treat parkinson disease in the USA. It has been approved in Europe to treat parkinson disease. The pharmaceutical is active against catechol O-methyltransferase. In addition, it is known to target catechol O-methyltransferase.

 

Trade Name

 

Tasmar
 

Common Name

 

tolcapone
 

ChEMBL ID

 

CHEMBL1324
 

Indication

 

parkinson disease
 

Drug Class

 

Catechol-O-methyltransferase (COMT) inhibitors

Image (chem structure or protein)

Tolcapone structure rendering